Abstract
Background
Hepatic myofibroblasts are relevant for pathogenesis of S. mansoni infection. In normal liver, these perisinusoidal cells are quiescent, express the lipocyte phenotype, and are located in the Disse’s space, being the major site of vitamin A storage. When activated, they convert to myofibroblasts and contribute to granulomatous and diffuse liver fibrosis. In the present work, we observed that myofibroblasts obtained from granulomatous periovular inflammatory reactions in schistosome-infected mice (GR-MF) produce in vitro immunomodulatory cytokines for eosinophil activation: IL-5 and eotaxin.
Methods and results
The secretory activity of GR-MF was detected after TGF-β and IL-13 stimulation using 2D and 3D cell culture systems. In a mixed co-culture system using GR-MF with hematopoietic bone marrow cells from infected mice, we observed eosinophil survival that was dependent upon IL-5 and eotaxin, since antibodies against this cytokines decreased eosinophil population, as measured by eosinophil peroxidase activity.
Conclusion
These results indicate that GR-MF may contribute to maintenance of local eosinophilia in schistosomal hepatic granulomas, and can function as immunoregulatory cells, besides their role in production of fibrosis.
Electronic supplementary material
The online version of this article (doi:10.1186/s13071-015-1197-3) contains supplementary material, which is available to authorized users.
Keywords: Liver myofibroblasts, IL-5, Eotaxin, Schistosoma mansoni, Eosinophil granulocyte
Background
Schistosomiasis is one of the major endemic parasitic diseases in the world. Schistosoma mansoni, S. haematobium, and S. japonicum are the species of major medical relevance for humans [1, 2]. The host tissue injuries mostly occur in response to schistosome eggs deposited in the intestinal venous circulation, from which they reach the intestinal lumen, and are subsequently eliminated. Alternatively, they are brought into liver by the mesenteric and portal circulations, being entrapped in the hepatic tissue, where they remain, eliciting formation of inflammatory granulomas, which are a response to eggs and myracidum-produced secreta that diffuse into the adjacent tissues [3, 4]. Consequently, one of the major features of schistosomiasis is a chronic liver inflammation and fibrosis.
In the acute phase of infection, the systemic and the periovular granulomatous reactions represent a classical Th2 response, orchestrated by CD4+ T cells, with a rich infiltration of eosinophils and macrophages. During the chronic phase, installation of an immune response controlled by Th1, Th17 and T regulatory cells and reduction of the granuloma size are observed, in parallel to increased fibrosis [3, 5–7].
Similar to other parasites infections, schistosomiasis is hyperergic in the acute phase of the disease, with high levels of inflammatory mediators including the stimulators of eosinophil production and mobilization. In this phase, eosinophils are essentially produced in the bone marrow, where up to 50 % of the myeloid cell population may be involved in eosinopoiesis. The circulating ones are readily mobilized into the infected tissues, and only immature eosinophils are found in the blood [8]. Their production is essentially dependent upon IL-5 [9].
In the chronic phase of schistosomiasis, a moderate increase of eosinophil precursors in bone marrow is associated with a mild blood eosinophilia. The intense tissue eosinophilia is dependent upon the peripheral production of myeloid cells. This occurs essentially in sites where schistosome eggs are deposited: within the mesenteric vessels of the intestinal wall and in the adjacent tissues, as well as within the intrahepatic portal venous vascular system in which eggs are trapped [7].
In the abdominal cavity of mice with chronic schistosomiasis, experimental induction of eosinopoiesis was correlated with mobilization of macrophages [10]. Alternatively, it was associated with coelom-associated lympho-myeloid tissue (milky spots), which occasionally grew in large polypoid structures with rich eosino- and plasmacytogenesis [11, 12]. Within these structures, as well as in the omentum, myelopoiesis was associated with macrophages and with the adipose tissue stroma, which produced the major hemopoietins (GM-CSF, M-CSF, G-CSF, IL-5) as well as SDF-1α, potentially involved in homing of circulating progenitors. Notably, the normal stroma produced LIF, while schistosome-infected mice stroma produced SCF. The latter one may be associated with induction of an intense proliferation of myeloid cells [13].
Similar to the abdominal cavity, in chronic schistosomiasis a hepatic eosinopoiesis was described in two scenarios. Eosinopoietic foci were observed within the sinusoids, in close contact with hypertrophic Kupffer-cells but not with perisinusoidal cells. The eosinophil progenitors and their maturation within these foci were synchronized, suggesting a local clonogenic growth of exogenous progenitor cells retained in the liver tissue [14]. Conversely, groups of eosinophil granulocytes in different stages of maturation were observed within the periovular granulomas, indicating a continuous active input of myeloid progenitors. They were in close contact with macrophages and with extracellular matrix containing collagen and proteoglycans [15]. Stimulation of eosinopoiesis was traced to factors produced by macrophages, but production of IL-5 could not be demonstrated [8, 16]. Similar to mesenteric stroma, connective tissue cells obtained from granulomas, which are at least in part derived from perisinusoidal cells, are a rich source of hemopoietins [17]. Moreover, under stimulation by TNFα, the GR-MF stroma produces SCF that sustains proliferation of myeloid cells [18]. Hepatic stellate cells are now considered to belong to the group of mesenchymal perivascular stroma cells, which participate in tissue reaction to injury [19]. When activated, they are also involved in regulation of hepatic inflammation and immunity through the expression of inflammatory and immune regulatory molecules [20].
In the present study, we have addressed the question of whether granuloma-derived myofibroblasts stimulated with TGF-β and IL-13, the pro-fibrogenic cytokines, can promote and sustain production and survival of eosinophil granulocytes. We have focused our attention on IL-5 and eotaxin production in 2D and 3D cell culture systems. We propose that GR-MF have a major role in production, maintenance and activation of eosinophil granulocytes in chronic inflammatory tissue reactions to parasites.
Methods
Ethics statement
This study was carried out in accordance with the recommendations of the Guide for Care and Use of Laboratory Animals of the Brazilian National Council of Animal Experimentation. The protocols were approved by the Oswaldo Cruz Foundation Animal Welfare Committee (CEUA LW-32/12).
Histological preparations
For histological analyses, animals were sacrificed after 90 days of infection. Livers were removed, cut into 0.5 mm thick slices, washed in cold saline and fixed in Bouin’s fixative. After 6 h of fixation, specimens were dehydrated in alcohol, and embedded in paraffin. Sections of 5 μm were obtained and stained with Hematoxylin-eosin and Masson’s trichrome staining.
For Masson’s Trichrome stain, briefly, slides were placed in Bouin’s solution for 1 h at 56 °C, then stained with Weigert’s hematoxylin (10 min; Sigma-Aldrich, St. Louis, MO), followed by Biebrich scarlet acid fuchsin (5 min; Sigma-Aldrich), phosphomolybdic/phosphotungstic acid solution (10 min; Sigma-Aldrich), and aniline blue (5 min; Sigma-Aldrich).
For α-smooth muscle actin (α-SMA) immunofluorescence, paraffin-embedded sections were dewaxed and hydrated and washed several times in PBS and further treated with 50nM NH4Cl (30 min), 0.05 % saponin/0.1 M PBS (30 min) and 0.05 % gelatin/0.05 % saponin/PBS (30 min). Cells were incubated with human monoclonal anti-SMA (Sigma-Aldrich, Inc., St. Louis, MO) diluted 1:400 in 0.05 % gelatin/0,05%saponin/PBS as the primary antibody at 4 °C, overnight. Thereafter, sections were incubated with anti-human Alexa Fluor® 546 (Life Technologies, Inc.) diluted 1:1000. Sections were examined by confocal microscopy Olympus FV-1000.
Isolation and purification of primary murine hepatic myofibroblasts derived from granulomas of schistosome-infected mice
C3H/HeN mice were obtained from the colony-breeding unit of the Oswaldo Cruz Foundation (Rio de Janeiro, Brazil). Mice were infected by 30–40 cercariae of Schistosoma mansoni (BH strain, Institute Oswaldo Cruz, RJ). Mice were killed 90 days after infection, periovular granulomas were isolated from mechanically homogenized liver tissue by sedimentation, and digested by collagenase 1A (1 mg/mL) (Sigma-Aldrich, Inc., St. Louis, MO). The harvested cells were seeded into 25 cm2 tissue culture flask in DMEM with 10 % fetal bovine serum (FBS). Cells were subcultured by trypsinization that eliminated the trypsin-resistant granuloma macrophages. After the fourth passage, a homogeneous population of myofibroblasts derived from hepatic granulomas were thus obtained (Additional file 1: Figure S1). These cells, named GR-MF, were fully described and characterized in previous studies [21–24].
Treatments
GR-MF maintained in DMEM with 2 % FBS, were stimulated with TGF-β (Peprotech) (30 and 60 ng/mL) and IL-13 (Peprotech) (40 ng/mL). After 24 h, cells were collected for mRNA extraction, and supernatants were stored at -20 °C for quantification of IL-5, eotaxin and collagen.
Three-dimensional (3D) culture of GR-MF
GR-MF monolayers were trypsinizated and cells were seeded in 1 % agarose- coated round-bottom 96-well plates. Cells were stimulated with TGF-β (30 ng/mL) and IL-13 (40 ng/mL). Spheres were observed and collected at day 4 for histological analysis, and supernatants were stored at -20 °C for quantification of IL-5, eotaxin and collagen. The diameters were measured using digital images.
Histological preparations of spheroids
For histological analyses, spheroids were washed in cold saline and fixed in Bouin’s solution. After 4 h fixation, specimens were dehydrated in alcohol and embedded in paraffin. Sections of 5 μm were obtained and stained with Hematoxylin and Eosin (HE), and a Modified Sirius Red technique for collagen [25].
For α-SMA staining, paraffin-embedded sections were dewaxed and hydrated. After inhibition of endogenous peroxidase, sections were incubated for 1 h with 5 % BSA/0.1 % triton X-100/0.05 % tween-20/10 % normal goat serum/PBS followed by incubation of monoclonal anti α-SMA (1:400, Sigma-Aldrich, Inc., St. Louis, MO) overnight at 4 °C in a humid chamber. α-SMA was detected with a biotinylated anti mouse IgG (BA-4001, Vector Laboratories; Burlingame, CA, USA) and developed with avidin-peroxidase (1:50 in PBS, Sigma Immuno Chemicals, St. Louis, MO, E-8 8386), using diaminobenzidine as chromogen. Sections were counterstained with Harris’ hematoxylin. As negative controls, sections were incubated with non-immune mouse serum.
mRNA extraction and real time reverse transcriptase-polymerase chain reaction (RT-PCR)
mRNA was extracted from 0.5 to 1 × 106 cells using TRIzol® Reagent following standard protocols. Total RNA was dissolved in water, quantified and stored at -20 °C. cDNA was synthesized from 1 μg total RNA. RNA was primed with 0.5 μg oligo-(dT) primer, denatured (10 min at 64 °C) and cooled on ice. The following reagents were mixed and added: 10 mM of each deoxynucleoside triphosphate (dNTP), 6 μL 5X reverse transcriptase (RT) buffer, 0.1 mM DTT and 200 U of MLV-RT. Reaction was performed by incubation for 1 h at 37 °C.
During amplification, we used pre-designed TaqMan Gene Expression Assays (Applied Biosystems), according to the manufacturer’s instructions, for IL-5 (NCBI RefSeq: NM_010558.1), eotaxin (NCBI RefSeq: NM_011330.3) and GAPDH (NCBI RefSeq: NM_001289726.1). The qPCR reaction was performed with a final volume of 25 μL, containing 2μL of cDNA, 12.5 μL of master mix (Applied Biosystems), and 250 nmol primers and probe in optical 96-well plates. The fluorescence emission from each reaction was measured three times during the annealing/extension, and amplification plots were analyzed using software from Applied Biosystems. The gene expression data were normalized using GAPDH as housekeeping gene.
Immunofluorescence analysis of GR-MF
GR-MF were seeded into 24-well culture plates at a concentration of 1 × 104 cells/well, in 500 μL standard culture medium, and fixed after 2 days culture. Cells were washed with HBSS solution and fixed in 4 % paraformaldehyde in PBS buffer, pH 7.4 for 15 min. After fixation, single-cell preparations were washed several times in PBS and further treated with 50 nM NH4Cl (30 min), 0.05 % saponin/PBS (30 min) and 0.05 % gelatin/0.05%saponin/PBS (30 min). Cells were treated with primary antibody, rat monoclonal anti-CCL11/eotaxin (R&D Systems) 5 μg/mL diluted 0.05 % gelatin/0.05%saponin/PBS, at 4 °C, overnight. Thereafter, cells were treated with a biotinylated IgG goat anti-rat antibody (Vector Labs) at the dilution indicated by the manufacturer. Fluorescence labeling was performed with extravidinCy3 (Sigma-Aldrich, Inc., St. Louis, MO) diluted 1:600. In both protocols, cells were examined with an Olympus epifluorescence microscope, and images were acquired using the ImagePro program.
IL-5 and eotaxin measurement
IL-5 and eotaxin in the supernatants of untreated and treated GR-MF were assayed by ELISA according to the manufacturer’s instructions (R&D Systems).
Proliferation assay
GR-MF were seeded into 24-well culture plates and stimulated with TGF-β (30 and 60 ng/mL), diluted in DMEM with 2 % fetal bovine serum. After 20 h, we added 0.5 μCi/mL 3[H]-thymidine and incubated in 5 % CO2 at 37 °C for 4 h. Cells were washed three times with PBS and harvest with 1 mL 0.1 % Triton/PBS. The solubilized cell solution was added into 2 mL scintillation vials and counted in a scintillation counter (Beckman LS 6500).
Collagen measurement
Collagen was quantified in supernatants of untreated and treated GR-MF using SircolKit (Biocolor, UK). The result was expressed as μg of collagen/mg total protein.
Co-culture of GR-MF and hematopoietic bone marrow cells
GR-MF were plated on glass coverslips to form a monolayer. After 4–6 days, a cell fraction of nonadherent mononuclear bone marrow cells of schistosome infected C3H/HeN mice were added under GR-MF semi-confluent monolayer. The cells were incubated with 5 % CO2 at 37 °C within DMEM with 5 % FBS. The glass slides were collected 5 and 7 days after co-culture for morphological analysis of granulocytes eosinophils using May-Grünwald and Giemsa stains (Sigma Aldrich). For 3D co-culture, GR-MF in suspension were co-cultured with non-adherent mononuclear bone marrow cells of schistosome-infected C3H/HeN mice and seeded together in agarose 1 % coated round-bottom 96-well plates. Spheres were observed and collected at day 4 for histological analysis.
Eosinophil peroxidase (EPO) detection assay
A colorimetric assay for eosinophil peroxidase was used to detect eosinophils in the co-culture of GR-MF with bone marrow cells. The substrate solution consists of 0.1 mM o-ophenylenediamine (OPD) in 0.05 M Tris–HCl buffer pH 8.0 containing 1 mM hydrogen peroxide, as described by Strath et al, 1985 [26]. The cell lysates were obtained by freezing, and total protein was normalized by BCA protein Kit.
Statistical analysis
Statistical analysis was done using analysis of variance and the paired and unpaired Student t test. Results are expressed as mean ± SEM, and differences were considered significant at a P value < 0.05.
Results
Schistosome hepatic granulomas characterization
Schistosomiasis is characterized by an intense periovular granulomatous reaction, with activation of fibrogenic cells and collagen deposition. In our experimental model of the chronic phase of the disease, we observed an intense deposition of collagen within granulomas, as shown by Masson’s trichrome staining (Fig. 1a), as well the immunofluorescence for α-SMA (Fig. 1b), indicating GR-MF activation within granulomas.
GR-MF characterization and activation in three-dimensional (3D) culture system
We detected myofibroblastic cells positive for smooth muscle α-actin around granulomas (Fig. 1b), potentially generated by activation and migration of adjacent perisinusoidal stellate cells and/or mobilization of circulating mesenchymal cell progenitors, and they were therefore termed here “granuloma myofibroblasts” (GR-MF).
The role of TGF-β on activation, proliferation and migration of GR-MF has been well described, and confirmed in our in vitro model, as shown in Fig. 2a. TGF-β stimulates an increased synthesis of extracellular matrix proteins by connective tissue cells during granulomatous liver reaction [27]. In order to study a model closer to the structure and to the kinetics of myofibroblast cell activation within granulomas, we used a 3D culture system in spheroids, and reported that GR-MF retained their phenotype by immunohistochemistry for α-smooth muscle actin (Fig. 2b). We observed that GR-MF spheroids stimulated with TGF-β and IL-13 showed larger diameters than the untreated spheroids (Fig. 2c and d). These differences were observed between stimulated and untreated spheroids in all the days analyzed. We observed a significant decrease in the size of spheroids from the second to the 4th day in culture. These data confirm the capacity of GR-MF to respond to pro-inflammatory stimuli as observed previously in the 2D system. While we observed that TGF-β stimulates GR-MF proliferation (Fig. 2a), we also reported an increased secretion of collagen into the supernatant of stimulated cells (Fig. 3a). Histological analysis of GR-MF spheroids also illustrated the degree of cell activation. We observed that the arrangement of the cells, by HE staining, and collagen fibers, by modified Sirius red staining (optical and confocal microscope analyses), from spheroids stimulated with TGF-β and IL-13 are more concentric and elongated when compared to non-stimulated spheroids (Fig. 3b). We also observed an increased amount of collagen in the supernatant of GR-MF spheroids stimulated with TGF-β and IL-13 (Fig. 3c). Therefore, these results show that GR-MF upon pro-fibrotic stimulation behave differently from non-stimulated cells.
IL-5 and eotaxin detection in GR-MF
During infection by S. mansoni, there is an intense extramedullar proliferation of hematopoietic cells, mainly eosinophils, in hepatic granuloma [10, 16]. Furthermore, studies support the hypothesis that the GR-MF have similar characteristics of the hematopoietic bone marrow stroma, and are able to sustain myelopoiesis both in vivo and in vitro [17]. Therefore, to investigate whether GR-MF are able to produce and secrete cytokines important in eosinophilia, we evaluated the expression of IL-5 and eotaxin, two relevant cytokines that control eosinophils. We demonstrated that GR-MF can produce IL-5 spontaneously in vitro, as shown by mRNA detection (Fig. 4a) and by ELISA in the supernatant of these cultured cells (Fig. 4b). When cells were stimulated with TGF-β and IL-13, we detected an enhanced IL-5 mRNA and protein production by treated cells. The same phenomenon was observed when IL-5 was measured into supernatant of stimulated spheroids (Fig. 4c). Some studies have demonstrated that eotaxin, may be associated with extracellular matrix proteoglycans [28]. While myofibroblasts are involved in extracellular matrix production within granulomas, we considered that they could be also an important source of the eotaxin production. Under normal culture conditions, GR-MF express eotaxin mRNA (Fig. 5a) and secrete basal levels of this cytokine into their supernatant (Fig. 5b). We also could detect by immunofluorescence the expression of eotaxin in vitro by non-stimulated cells (Fig. 5c). While both TGF-β and IL-13 stimulation induced production of IL-5, only the stimulation with IL-13 was able to induce a significant increase in the expression of eotaxin mRNA and in its secretion by GR-MF. Similar data were also observed in the more complex 3D system of GR-MF culture (Fig. 5d). These data indicate that the production of cytokines and chemokines by GR-MF is a highly regulated and stimulus-specific phenomenon.
Eosinophils in GR-MF microenvironment
We have reported that the GR-MF are cells with high pro-inflammatory potential, through production of leukotrienes, cytokines and chemokines [13]. Our data show that GR-MF express relevant stimuli for eosinophils, IL-5 and eotaxin, under stimulation with fibrogenic stimuli. Further, we have investigated the capacity of cultured-GR-MF to sustain eosinophils in vitro.
By employing co-cultures of GR-MF with non-adherent cells from bone marrow, in both monolayer and spheroids models, we have observed that GR-MF were able to sustain eosinophil population in vitro. We observed the formation of eosinophilic clusters within 7 days in co-cultures of GR-MF monolayer (Fig. 6a), and after 3 days in co-culture with GR-MF spheroids (Fig. 6b). Eosinophilic clusters were mostly detected on GR-MF monolayers when co-cultured with hematopoietic cells from schistosome-infected mice rich in eosinophil precursors.
In order to better elucidate the mechanisms involved in the ability of GR-MF monolayers to control eosinophil populations observed in co-cultures, we evaluated the role of GR-MF-derived IL-5 and eotaxin. Co-cultured GR-MF monolayers and hematopoietic cells from schistosome-infected mice were treated with neutralizing monoclonal antibodies against IL-5 or eotaxin. In order to monitor the eosinophil granulocyte population, after 5 days of co-cultures cells were disrupted and eosinophil peroxidase (an eosinophil protein marker) was measured in the cell lysate. Figure 6c shows that neutralization of IL-5 and eotaxin by monoclonal antibodies promotes a clear decrease of EPO levels in co-culture. These data suggest that the neutralization of GR-MF-derived IL-5 and eotaxin reduces GR-MF capacity to maintain eosinophil population in the co-culture and are in agreement with previous results showing that extra-medullary eosinopoiesis occurs within S. mansoni infection-induced liver granuloma [8]. Altogether, we can conclude that the GR-MF have an important role in the eosinophilia observed in liver granuloma during infection.
Discussion
In the experimental model of S. mansoni infection, we observed that myofibroblasts obtained from schistosome granulomas are able to respond to TGF-β and IL-13 stimuli in vitro, increasing the rate of proliferation and collagen production. In order to better evaluate the activation and the role of GR-MF during infection, we used a three-dimensional model of cell culture in spheroids. The three-dimensional models are better than conventional cultures, since they promote cell–cell and cell–extracellular matrix contacts that are necessary for many cellular function such as differentiation, proliferation, cell death, apoptosis and angiogenesis [29]. We observed that the GR-MF are able to form spheroids, keeping their myofibroblast phenotype.
In order to identify an immunoregulatory role of these cells during formation of hepatic granulomas, we analyzed the production of IL-5 and eotaxin, important mediators involved in the proliferation and differentiation of eosinophils [30]. In our experiments, we detect by real-time PCR and ELISA assays, that GR-MF express and secrete IL-5 and eotaxin. When cells were stimulated with TGF-β and IL-13, an increased production of IL-5 was observed, while IL-13, but not TGF- β, stimulated eotaxin production. Pro-fibrogenic cytokines such as IL-13 and TGF-β are able to stimulate cells in 3D spheroids, triggering an increase in diameter, in collagen production and secretion of IL-5 and eotaxin in the supernatant. When performing the histological analysis of spheroids, we observed that stimulated spheroids have a completely different arrangement of cells and collagen fibers, reflecting the activation of these cells induced by IL-13 and TGF-β.
During fibrosis progression, hepatocellular damage and inflammation trigger complex cellular events, including myofibroblasts activation that result in collagen deposition and the disruption of the normal liver architecture [19]. Recent studies have shown that hepatic myofibroblasts have origin from a resident stellate cells in the liver parenchyma [31]. Their activation as a hallmark during the development of periovular granulomas [32].
Besides their role in fibrosis, activated stellate cells participate in various immunomodulatory events, amplifying the inflammatory response through the production of chemokines, such as MCP-1 and RANTES, expression of chemokine receptors, as CCR5, and could behave as antigen presenting cells [33, 34]. Bacterial endotoxin also stimulates stellate cells through alteration in expression of numerous relevant genes, such as the down regulation of TGF-β1 [20]. They were also described as bystander in the activation of Tregs, due to their ability to produce and store retinoic acid into lipid bodies, that is important to promote TGF-β-dependent Foxp3+ Treg induction and suppression of Th17 differentiation [35].
In the murine model of schistosomiasis, myofibroblasts derived from hepatic granulomas have also an immunoregulatory function expressing and producing a number of proinflammatory cytokines such as GM-CSF and SCF, related to liver tissue repair and sustaining the development of inflammation [10, 18, 36]. It was also reported that granuloma myofibroblasts are able to release cysteinyl-leukotrienes in a TGF-β regulated manner contributing to the pathogenesis and tissue repair in schistosomiasis [21].
During chronic S. mansoni infection, the number of eosinophil precursors increases in the bone marrow and in extramedullary myelopoietic foci [10, 37] due not only to bone marrow production but, similarly to a monomacrophagic population, and to their amplification in peripheral tissues [8]. It is well established that leukocyte interactions within stromal cells and endothelial cells are essential for its recruitment into inflamed tissues [38].
Considering the production of IL-5 and eotaxin by activated GR-MF, we monitored the ability of GR-MF to promote eosinophil survival when co-cultured in vitro with non-adherent bone marrow cells from S. mansoni infected mice. We also observed the presence of eosinophils in multicellular spheroids of GR-MF containing non-adherent bone marrow cells from S. mansoni infected mice. When we use neutralizing antibodies to block IL-5 and eotaxin in the co-culture, we observed a low EPO activity in the co-cultures indicating that these cytokines produced by GR-MF are important for eosinophil survival. Together, these data suggest an important role of GR-MF for eosinophil recruitment and survival in periovular granulomas.
Conclusion
The present research shows that GR-MF derived from periovular granulomas of S. mansoni-infected mice produce IL-5 and eotaxin under TGF-β and IL-13 stimulation, and provides evidence that these molecules are relevant for eosinophil production and maintenance in hepatic granulomas.
Acknowledgments
We thank Dr. Silvana Thiengo, who generously provided cercariae from S. mansoni for mice infection.
Additional files
Footnotes
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed the experiments: LAP, CBM, PTB, MCEC and SACP. Performed the experiments: LAP and CB; Analyzed the data: LAP, CB, CBM, PTB, MCEC and SACP; Contributed reagents/materials/analysis tools: CBM, PTB, MCEC, PMRS, RB and SACP; Wrote the paper: LAP, CBM, PTB, RB and SACP. All authors read and approved the final version of the manuscript.
Contributor Information
Ligia Almeida Paiva, Email: ligia@ioc.fiocruz.br, Email: ligia.paiva@gmail.com.
Camila Brand, Email: camilabrandc@gmail.com.
Christianne Bandeira-Melo, Email: cbmelo@biof.ufrj.br.
Patricia Torres Bozza, Email: pbozza@gmail.com.
Marcia Cury El-Cheikh, Email: marcia@histo.ufrj.br.
Patricia Martins Silva, Email: patsilva1910@gmail.com.
Radovan Borojevic, Email: rrborojevic@gmail.com.
Sandra Aurora Chavez Perez, Email: sandrarodrigues@far.fiocruz.br, Email: sacprodrigues@gmail.com.
References
- 1.King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005;365:1561–1569. doi: 10.1016/S0140-6736(05)66457-4. [DOI] [PubMed] [Google Scholar]
- 2.van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003;86:125–139. doi: 10.1016/S0001-706X(03)00029-9. [DOI] [PubMed] [Google Scholar]
- 3.Andrade ZA. Schistosomiasis and liver fibrosis. Parasite Immunol. 2009;31:656–663. doi: 10.1111/j.1365-3024.2009.01157.x. [DOI] [PubMed] [Google Scholar]
- 4.Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev. 2004;201:156–167. doi: 10.1111/j.0105-2896.2004.00176.x. [DOI] [PubMed] [Google Scholar]
- 5.Chuah C, Jones MK, Burke ML, McManus DP, Gobert GN. Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends Parasitol. 2014;30:141–150. doi: 10.1016/j.pt.2013.12.009. [DOI] [PubMed] [Google Scholar]
- 6.Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol. 2000;164:2585–2591. doi: 10.4049/jimmunol.164.5.2585. [DOI] [PubMed] [Google Scholar]
- 7.Borojevic R. Experimental murine schistosomiasis mansoni: establishment of the chronic phase of the disease. Mem Inst Oswaldo Cruz. 1992;87(Suppl 4):171–174. doi: 10.1590/S0074-02761992000800026. [DOI] [PubMed] [Google Scholar]
- 8.El-Cheikh MC, Borojevic R. Extramedullar proliferation of eosinophil granulocytes in chronic schistosomiasis mansoni is mediated by a factor secreted by inflammatory macrophages. Infect Immun. 1990;58:816–821. doi: 10.1128/iai.58.3.816-821.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 1989;245:308–310. doi: 10.1126/science.2787531. [DOI] [PubMed] [Google Scholar]
- 10.Borojevic R, Cury El-Cheikh MC, Nicola MH. Schistosoma mansoni: control of extramedullar eosinophil myelopoiesis in chronically infected mice by inflammatory macrophages. Exp Parasitol. 1986;62:349–355. doi: 10.1016/0014-4894(86)90041-X. [DOI] [PubMed] [Google Scholar]
- 11.Lenzi HL, Oliveira DN, Pelajo-Machado M, Borojevic R, Lenzi JA. Coelom-associated lymphomyeloid tissue (milky spots): site of lymphoid and myelomonocytic cell generation. Braz J Med Biol Res. 1996;29:19–24. [PubMed] [Google Scholar]
- 12.Weinberg DF, Baldo-Correa E, Lenzi HL, Borojevic R. Schistosoma mansoni: peritoneal plasmacytogenesis and polypoid transformation of mesenteric milky spots in infected mice. Exp Parasitol. 1992;74:408–416. doi: 10.1016/0014-4894(92)90203-M. [DOI] [PubMed] [Google Scholar]
- 13.Pinho MF, Hurtado SP, El-Cheikh MC, Rossi MI, Dutra HS, Borojevic R. Myelopoiesis in the omentum of normal mice and during abdominal inflammatory processes. Cell Tissue Res. 2002;308:87–96. doi: 10.1007/s00441-002-0550-y. [DOI] [PubMed] [Google Scholar]
- 14.Borojevic R, Stocker S, Grimaud JA. Hepatic eosinophil granulocytopoiesis in murine experimental Schistosomiasis mansoni. Br J Exp Pathol. 1981;62:480–489. [PMC free article] [PubMed] [Google Scholar]
- 15.Geuskens M, Borojevic R, Van Gansen P. Eosinophil granulocytopoiesis in hepatic periovular granulomas during the chronic phase of experimental murine Schistosomiasis mansoni. Biol Cell. 1991;71:89–96. doi: 10.1016/0248-4900(91)90055-R. [DOI] [PubMed] [Google Scholar]
- 16.El-Cheikh MC, Dutra HS, Borojevic R. Eosinophil granulocyte proliferation and differentiation in schistosomal granulomas are controlled by two cytokines. Lab Invest. 1991;64:93–97. [PubMed] [Google Scholar]
- 17.Boloukhere M, Baldo-Correa E, Borojevic R. Experimental schistosomiasis mansoni: characterization of connective tissue cells in hepatic periovular granulomas. J Submicrosc Cytol Pathol. 1993;25:505–517. [PubMed] [Google Scholar]
- 18.Brito JM, Borojevic R. Liver granulomas in schistosomiasis: mast cell-dependent induction of SCF expression in hepatic stellate cells is mediated by TNF-alpha. J Leukoc Biol. 1997;62:389–396. doi: 10.1002/jlb.62.3.389. [DOI] [PubMed] [Google Scholar]
- 19.Anthony B, Allen JT, Li YS, McManus DP. Hepatic stellate cells and parasite-induced liver fibrosis. Parasit Vectors. 2010;3:60. doi: 10.1186/1756-3305-3-60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Harvey SA, Dangi A, Tandon A, Gandhi CR. The transcriptomic response of rat hepatic stellate cells to endotoxin: implications for hepatic inflammation and immune regulation. PLoS One. 2013;8:e82159. doi: 10.1371/journal.pone.0082159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Paiva LA, Maya-Monteiro CM, Bandeira-Melo C, Silva PM, El-Cheikh MC, Teodoro AJ, Borojevic R, Perez SA, Bozza PT. Interplay of cysteinyl leukotrienes and TGF-beta in the activation of hepatic stellate cells from Schistosoma mansoni granulomas. Biochim Biophys Acta. 1801;2010:1341–1348. doi: 10.1016/j.bbalip.2010.08.014. [DOI] [PubMed] [Google Scholar]
- 22.Alvarez-Silva M, Pinazo AC, el-Cheikh MC, Borojevic R. Myelopoietic competence of stroma composed of hepatic granuloma-derived connective tissue cells or skin fibroblasts. Braz J Med Biol Res. 1994;27:2143–2152. [PubMed] [Google Scholar]
- 23.Carvalho MA, Arcanjo K, Silva LC, Borojevic R. The capacity of connective tissue stromas to sustain myelopoiesis depends both upon the growth factors and the local intercellular environment. Biol Cell. 2000;92:605–614. doi: 10.1016/S0248-4900(01)01113-3. [DOI] [PubMed] [Google Scholar]
- 24.Guma FCR, Mello TG, Mermelstein CS, Fortuna VA, Wofchuk ST, Gottfried C, Guaragna RM, Costa ML, Borojevic R. Intermediate filaments modulation in an in vitro model of the hepatic stellate cell activation or conversion into the lipocyte phenotype. Biochem Cell Biol. 2001;79:409–417. doi: 10.1139/o01-027. [DOI] [PubMed] [Google Scholar]
- 25.Dolber PC, Spach MS. Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem. 1993;41:465–469. doi: 10.1177/41.3.7679127. [DOI] [PubMed] [Google Scholar]
- 26.Strath M, Warren DJ, Sanderson CJ. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J Immunol Methods. 1985;83:209–215. doi: 10.1016/0022-1759(85)90242-X. [DOI] [PubMed] [Google Scholar]
- 27.Saile B, Matthes N, Knittel T, Ramadori G. Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology. 1999;30:196–202. doi: 10.1002/hep.510300144. [DOI] [PubMed] [Google Scholar]
- 28.Culley FJ, Fadlon EJ, Kirchem A, Williams TJ, Jose PJ, Pease JE. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines. Eur J Immunol. 2003;33:1302–1310. doi: 10.1002/eji.200323509. [DOI] [PubMed] [Google Scholar]
- 29.Rossi MI, Barros AP, Baptista LS, Garzoni LR, Meirelles MN, Takiya CM, Pascarelli BM, Dutra HS, Borojevic R. Multicellular spheroids of bone marrow stromal cells: a three-dimensional in vitro culture system for the study of hematopoietic cell migration. Braz J Med Biol Res. 2005;38:1455–1462. doi: 10.1590/S0100-879X2005001000002. [DOI] [PubMed] [Google Scholar]
- 30.Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008;38:709–750. doi: 10.1111/j.1365-2222.2008.02958.x. [DOI] [PubMed] [Google Scholar]
- 31.Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, Pradere JP, Schwabe RF. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823. doi: 10.1038/ncomms3823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209–218. doi: 10.1172/JCI24282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, Bursill CA, Llovet JM, Brenner DA, Schwabe RF. CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest. 2009;119:1858–1870. doi: 10.1172/JCI37444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, Liblau RS, Gressner AM, Kaufmann SH. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity. 2007;26:117–129. doi: 10.1016/j.immuni.2006.11.011. [DOI] [PubMed] [Google Scholar]
- 35.Ichikawa S, Mucida D, Tyznik AJ, Kronenberg M, Cheroutre H. Hepatic stellate cells function as regulatory bystanders. J Immunol. 2011;186:5549–5555. doi: 10.4049/jimmunol.1003917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Alvarez-Silva M, da Silva LC, Borojevic R. Cell membrane-associated proteoglycans mediate extramedullar myeloid proliferation in granulomatous inflammatory reactions to schistosome eggs. J Cell Sci. 1993;104(Pt 2):477–484. doi: 10.1242/jcs.104.2.477. [DOI] [PubMed] [Google Scholar]
- 37.Lenzi HL, Pacheco RG, Pelajo-Machado M, Panasco MS, Romanha WS, Lenzi JA. Immunological system and Schistosoma mansoni: co-evolutionary immunobiology. What is the eosinophil role in parasite-host relationship? Mem Inst Oswaldo Cruz. 1997;92:19–32. doi: 10.1590/S0074-02761997000800005. [DOI] [PubMed] [Google Scholar]
- 38.McGettrick HM, Butler LM, Buckley CD, Rainger GE, Nash GB. Tissue stroma as a regulator of leukocyte recruitment in inflammation. J Leukoc Biol. 2012;91:385–400. doi: 10.1189/jlb.0911458. [DOI] [PubMed] [Google Scholar]